nodes	percent_of_prediction	percent_of_DWPC	metapath
Secobarbital—CYP2C8—Mometasone—systemic scleroderma	0.234	0.349	CbGbCtD
Secobarbital—CYP1A2—Pentoxifylline—systemic scleroderma	0.122	0.182	CbGbCtD
Secobarbital—CYP1A2—Leflunomide—systemic scleroderma	0.117	0.174	CbGbCtD
Secobarbital—CYP2C9—Leflunomide—systemic scleroderma	0.105	0.157	CbGbCtD
Secobarbital—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0932	0.139	CbGbCtD
Secobarbital—Anaemia megaloblastic—Azathioprine—systemic scleroderma	0.0183	0.0559	CcSEcCtD
Secobarbital—Anaemia megaloblastic—Methotrexate—systemic scleroderma	0.00739	0.0225	CcSEcCtD
Secobarbital—Liver injury—Captopril—systemic scleroderma	0.00589	0.0179	CcSEcCtD
Secobarbital—Liver injury—Azathioprine—systemic scleroderma	0.00514	0.0157	CcSEcCtD
Secobarbital—Hepatocellular injury—Captopril—systemic scleroderma	0.00495	0.0151	CcSEcCtD
Secobarbital—Liver injury—Leflunomide—systemic scleroderma	0.00485	0.0148	CcSEcCtD
Secobarbital—Liver injury—Mycophenolic acid—systemic scleroderma	0.00463	0.0141	CcSEcCtD
Secobarbital—Apnoea—Mycophenolic acid—systemic scleroderma	0.00459	0.014	CcSEcCtD
Secobarbital—Hepatocellular injury—Azathioprine—systemic scleroderma	0.00432	0.0132	CcSEcCtD
Secobarbital—Thinking abnormal—Mycophenolic acid—systemic scleroderma	0.00425	0.013	CcSEcCtD
Secobarbital—Hepatocellular injury—Leflunomide—systemic scleroderma	0.00408	0.0124	CcSEcCtD
Secobarbital—Respiratory failure—Mycophenolic acid—systemic scleroderma	0.00397	0.0121	CcSEcCtD
Secobarbital—Hepatocellular injury—Mycophenolic acid—systemic scleroderma	0.00389	0.0119	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Captopril—systemic scleroderma	0.00381	0.0116	CcSEcCtD
Secobarbital—Liver injury—Mycophenolate mofetil—systemic scleroderma	0.00365	0.0111	CcSEcCtD
Secobarbital—Apnoea—Mycophenolate mofetil—systemic scleroderma	0.00362	0.011	CcSEcCtD
Secobarbital—Ataxia—Captopril—systemic scleroderma	0.00338	0.0103	CcSEcCtD
Secobarbital—Mental disability—Mycophenolic acid—systemic scleroderma	0.00338	0.0103	CcSEcCtD
Secobarbital—Thinking abnormal—Mycophenolate mofetil—systemic scleroderma	0.00336	0.0102	CcSEcCtD
Secobarbital—Respiratory failure—Mycophenolate mofetil—systemic scleroderma	0.00313	0.00954	CcSEcCtD
Secobarbital—Hepatocellular injury—Mycophenolate mofetil—systemic scleroderma	0.00307	0.00937	CcSEcCtD
Secobarbital—Injection site reaction—Mycophenolate mofetil—systemic scleroderma	0.00305	0.00931	CcSEcCtD
Secobarbital—Tension—Pentoxifylline—systemic scleroderma	0.0028	0.00854	CcSEcCtD
Secobarbital—Nervousness—Pentoxifylline—systemic scleroderma	0.00277	0.00846	CcSEcCtD
Secobarbital—Hypoxia—Methotrexate—systemic scleroderma	0.00274	0.00835	CcSEcCtD
Secobarbital—Hyperkinesia—Mycophenolate mofetil—systemic scleroderma	0.00268	0.00817	CcSEcCtD
Secobarbital—Mental disability—Mycophenolate mofetil—systemic scleroderma	0.00267	0.00813	CcSEcCtD
Secobarbital—Ataxia—Mycophenolic acid—systemic scleroderma	0.00266	0.0081	CcSEcCtD
Secobarbital—Agitation—Pentoxifylline—systemic scleroderma	0.00263	0.008	CcSEcCtD
Secobarbital—Angioedema—Pentoxifylline—systemic scleroderma	0.00261	0.00796	CcSEcCtD
Secobarbital—Hallucination—Captopril—systemic scleroderma	0.00247	0.00754	CcSEcCtD
Secobarbital—Anxiety—Pentoxifylline—systemic scleroderma	0.00242	0.00739	CcSEcCtD
Secobarbital—Ataxia—Lisinopril—systemic scleroderma	0.00239	0.0073	CcSEcCtD
Secobarbital—Confusional state—Pentoxifylline—systemic scleroderma	0.00235	0.00717	CcSEcCtD
Secobarbital—Shock—Pentoxifylline—systemic scleroderma	0.00229	0.00699	CcSEcCtD
Secobarbital—Angioedema—Mometasone—systemic scleroderma	0.00225	0.00687	CcSEcCtD
Secobarbital—Hypotension—Pentoxifylline—systemic scleroderma	0.00218	0.00664	CcSEcCtD
Secobarbital—Tension—Captopril—systemic scleroderma	0.00212	0.00648	CcSEcCtD
Secobarbital—Nervousness—Captopril—systemic scleroderma	0.0021	0.00641	CcSEcCtD
Secobarbital—Somnolence—Pentoxifylline—systemic scleroderma	0.00207	0.00632	CcSEcCtD
Secobarbital—Apnoea—Methotrexate—systemic scleroderma	0.00205	0.00626	CcSEcCtD
Secobarbital—Constipation—Pentoxifylline—systemic scleroderma	0.00199	0.00608	CcSEcCtD
Secobarbital—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00199	0.00607	CcSEcCtD
Secobarbital—Angioedema—Captopril—systemic scleroderma	0.00198	0.00603	CcSEcCtD
Secobarbital—Hallucination—Mycophenolic acid—systemic scleroderma	0.00195	0.00593	CcSEcCtD
Secobarbital—Syncope—Captopril—systemic scleroderma	0.00194	0.00592	CcSEcCtD
Secobarbital—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00192	0.00586	CcSEcCtD
Secobarbital—Loss of consciousness—Captopril—systemic scleroderma	0.0019	0.0058	CcSEcCtD
Secobarbital—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00184	0.00562	CcSEcCtD
Secobarbital—Hyperkinesia—Prednisone—systemic scleroderma	0.00182	0.00554	CcSEcCtD
Secobarbital—Bradycardia—Lisinopril—systemic scleroderma	0.00179	0.00547	CcSEcCtD
Secobarbital—Confusional state—Captopril—systemic scleroderma	0.00178	0.00543	CcSEcCtD
Secobarbital—Respiratory failure—Methotrexate—systemic scleroderma	0.00177	0.0054	CcSEcCtD
Secobarbital—Hallucination—Lisinopril—systemic scleroderma	0.00175	0.00534	CcSEcCtD
Secobarbital—Shock—Captopril—systemic scleroderma	0.00174	0.0053	CcSEcCtD
Secobarbital—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00172	0.00524	CcSEcCtD
Secobarbital—Depressed level of consciousness—Methotrexate—systemic scleroderma	0.00168	0.00512	CcSEcCtD
Secobarbital—Tension—Mycophenolic acid—systemic scleroderma	0.00167	0.00509	CcSEcCtD
Secobarbital—Nervousness—Mycophenolic acid—systemic scleroderma	0.00165	0.00504	CcSEcCtD
Secobarbital—Hypotension—Captopril—systemic scleroderma	0.00165	0.00503	CcSEcCtD
Secobarbital—Angioedema—Leflunomide—systemic scleroderma	0.00163	0.00497	CcSEcCtD
Secobarbital—Body temperature increased—Mometasone—systemic scleroderma	0.00159	0.00485	CcSEcCtD
Secobarbital—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00479	CcSEcCtD
Secobarbital—Somnolence—Captopril—systemic scleroderma	0.00157	0.00479	CcSEcCtD
Secobarbital—Agitation—Mycophenolic acid—systemic scleroderma	0.00156	0.00477	CcSEcCtD
Secobarbital—Dizziness—Pentoxifylline—systemic scleroderma	0.00154	0.0047	CcSEcCtD
Secobarbital—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00154	0.00468	CcSEcCtD
Secobarbital—Syncope—Mycophenolic acid—systemic scleroderma	0.00153	0.00465	CcSEcCtD
Secobarbital—Anxiety—Leflunomide—systemic scleroderma	0.00151	0.00461	CcSEcCtD
Secobarbital—Constipation—Captopril—systemic scleroderma	0.00151	0.00461	CcSEcCtD
Secobarbital—Tension—Lisinopril—systemic scleroderma	0.0015	0.00459	CcSEcCtD
Secobarbital—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.0015	0.00456	CcSEcCtD
Secobarbital—Nervousness—Lisinopril—systemic scleroderma	0.00149	0.00454	CcSEcCtD
Secobarbital—Vomiting—Pentoxifylline—systemic scleroderma	0.00148	0.00452	CcSEcCtD
Secobarbital—Rash—Pentoxifylline—systemic scleroderma	0.00147	0.00448	CcSEcCtD
Secobarbital—Dermatitis—Pentoxifylline—systemic scleroderma	0.00147	0.00448	CcSEcCtD
Secobarbital—Headache—Pentoxifylline—systemic scleroderma	0.00146	0.00445	CcSEcCtD
Secobarbital—Feeling abnormal—Captopril—systemic scleroderma	0.00146	0.00444	CcSEcCtD
Secobarbital—Anxiety—Mycophenolic acid—systemic scleroderma	0.00144	0.0044	CcSEcCtD
Secobarbital—Hypotension—Azathioprine—systemic scleroderma	0.00144	0.00439	CcSEcCtD
Secobarbital—Angioedema—Lisinopril—systemic scleroderma	0.0014	0.00427	CcSEcCtD
Secobarbital—Confusional state—Mycophenolic acid—systemic scleroderma	0.0014	0.00427	CcSEcCtD
Secobarbital—Body temperature increased—Captopril—systemic scleroderma	0.0014	0.00426	CcSEcCtD
Secobarbital—Nausea—Pentoxifylline—systemic scleroderma	0.00138	0.00422	CcSEcCtD
Secobarbital—Syncope—Lisinopril—systemic scleroderma	0.00137	0.00419	CcSEcCtD
Secobarbital—Shock—Mycophenolic acid—systemic scleroderma	0.00137	0.00417	CcSEcCtD
Secobarbital—Hypotension—Leflunomide—systemic scleroderma	0.00136	0.00415	CcSEcCtD
Secobarbital—Loss of consciousness—Lisinopril—systemic scleroderma	0.00135	0.00411	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00134	0.00408	CcSEcCtD
Secobarbital—Tension—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00402	CcSEcCtD
Secobarbital—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.0013	0.00398	CcSEcCtD
Secobarbital—Anxiety—Lisinopril—systemic scleroderma	0.0013	0.00396	CcSEcCtD
Secobarbital—Hypotension—Mycophenolic acid—systemic scleroderma	0.0013	0.00396	CcSEcCtD
Secobarbital—Vomiting—Mometasone—systemic scleroderma	0.00128	0.0039	CcSEcCtD
Secobarbital—Feeling abnormal—Azathioprine—systemic scleroderma	0.00127	0.00387	CcSEcCtD
Secobarbital—Rash—Mometasone—systemic scleroderma	0.00127	0.00387	CcSEcCtD
Secobarbital—Dermatitis—Mometasone—systemic scleroderma	0.00127	0.00386	CcSEcCtD
Secobarbital—Confusional state—Lisinopril—systemic scleroderma	0.00126	0.00385	CcSEcCtD
Secobarbital—Headache—Mometasone—systemic scleroderma	0.00126	0.00384	CcSEcCtD
Secobarbital—Constipation—Leflunomide—systemic scleroderma	0.00125	0.0038	CcSEcCtD
Secobarbital—Somnolence—Mycophenolic acid—systemic scleroderma	0.00123	0.00376	CcSEcCtD
Secobarbital—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00376	CcSEcCtD
Secobarbital—Shock—Lisinopril—systemic scleroderma	0.00123	0.00375	CcSEcCtD
Secobarbital—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00374	CcSEcCtD
Secobarbital—Body temperature increased—Azathioprine—systemic scleroderma	0.00122	0.00372	CcSEcCtD
Secobarbital—Syncope—Mycophenolate mofetil—systemic scleroderma	0.0012	0.00367	CcSEcCtD
Secobarbital—Feeling abnormal—Leflunomide—systemic scleroderma	0.0012	0.00366	CcSEcCtD
Secobarbital—Nausea—Mometasone—systemic scleroderma	0.00119	0.00364	CcSEcCtD
Secobarbital—Ataxia—Methotrexate—systemic scleroderma	0.00119	0.00362	CcSEcCtD
Secobarbital—Constipation—Mycophenolic acid—systemic scleroderma	0.00119	0.00362	CcSEcCtD
Secobarbital—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00118	0.0036	CcSEcCtD
Secobarbital—Hypotension—Lisinopril—systemic scleroderma	0.00117	0.00356	CcSEcCtD
Secobarbital—Dizziness—Captopril—systemic scleroderma	0.00117	0.00356	CcSEcCtD
Secobarbital—Body temperature increased—Leflunomide—systemic scleroderma	0.00115	0.00351	CcSEcCtD
Secobarbital—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00114	0.00349	CcSEcCtD
Secobarbital—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00347	CcSEcCtD
Secobarbital—Hypersensitivity—Azathioprine—systemic scleroderma	0.00114	0.00346	CcSEcCtD
Secobarbital—Vomiting—Captopril—systemic scleroderma	0.00112	0.00342	CcSEcCtD
Secobarbital—Rash—Captopril—systemic scleroderma	0.00111	0.0034	CcSEcCtD
Secobarbital—Dermatitis—Captopril—systemic scleroderma	0.00111	0.00339	CcSEcCtD
Secobarbital—Somnolence—Lisinopril—systemic scleroderma	0.00111	0.00339	CcSEcCtD
Secobarbital—Headache—Captopril—systemic scleroderma	0.00111	0.00337	CcSEcCtD
Secobarbital—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00337	CcSEcCtD
Secobarbital—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.0011	0.00335	CcSEcCtD
Secobarbital—Shock—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00329	CcSEcCtD
Secobarbital—Hypersensitivity—Leflunomide—systemic scleroderma	0.00107	0.00327	CcSEcCtD
Secobarbital—Constipation—Lisinopril—systemic scleroderma	0.00107	0.00326	CcSEcCtD
Secobarbital—Bradycardia—Prednisone—systemic scleroderma	0.00106	0.00325	CcSEcCtD
Secobarbital—Nausea—Captopril—systemic scleroderma	0.00105	0.0032	CcSEcCtD
Secobarbital—Hallucination—Prednisone—systemic scleroderma	0.00104	0.00317	CcSEcCtD
Secobarbital—Feeling abnormal—Lisinopril—systemic scleroderma	0.00103	0.00314	CcSEcCtD
Secobarbital—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00312	CcSEcCtD
Secobarbital—Dizziness—Azathioprine—systemic scleroderma	0.00102	0.00311	CcSEcCtD
Secobarbital—Body temperature increased—Lisinopril—systemic scleroderma	0.000989	0.00302	CcSEcCtD
Secobarbital—Vomiting—Azathioprine—systemic scleroderma	0.00098	0.00299	CcSEcCtD
Secobarbital—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000975	0.00297	CcSEcCtD
Secobarbital—Rash—Azathioprine—systemic scleroderma	0.000972	0.00296	CcSEcCtD
Secobarbital—Dermatitis—Azathioprine—systemic scleroderma	0.000971	0.00296	CcSEcCtD
Secobarbital—Headache—Azathioprine—systemic scleroderma	0.000966	0.00294	CcSEcCtD
Secobarbital—Dizziness—Leflunomide—systemic scleroderma	0.000963	0.00294	CcSEcCtD
Secobarbital—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000937	0.00286	CcSEcCtD
Secobarbital—Vomiting—Leflunomide—systemic scleroderma	0.000926	0.00282	CcSEcCtD
Secobarbital—Hypersensitivity—Lisinopril—systemic scleroderma	0.000922	0.00281	CcSEcCtD
Secobarbital—Dizziness—Mycophenolic acid—systemic scleroderma	0.000919	0.0028	CcSEcCtD
Secobarbital—Rash—Leflunomide—systemic scleroderma	0.000918	0.0028	CcSEcCtD
Secobarbital—Dermatitis—Leflunomide—systemic scleroderma	0.000917	0.0028	CcSEcCtD
Secobarbital—Nausea—Azathioprine—systemic scleroderma	0.000916	0.00279	CcSEcCtD
Secobarbital—Headache—Leflunomide—systemic scleroderma	0.000912	0.00278	CcSEcCtD
Secobarbital—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000903	0.00275	CcSEcCtD
Secobarbital—Vomiting—Mycophenolic acid—systemic scleroderma	0.000883	0.00269	CcSEcCtD
Secobarbital—Rash—Mycophenolic acid—systemic scleroderma	0.000876	0.00267	CcSEcCtD
Secobarbital—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000875	0.00267	CcSEcCtD
Secobarbital—Headache—Mycophenolic acid—systemic scleroderma	0.00087	0.00265	CcSEcCtD
Secobarbital—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000867	0.00264	CcSEcCtD
Secobarbital—Nausea—Leflunomide—systemic scleroderma	0.000865	0.00264	CcSEcCtD
Secobarbital—Agitation—Prednisone—systemic scleroderma	0.000837	0.00255	CcSEcCtD
Secobarbital—Angioedema—Prednisone—systemic scleroderma	0.000832	0.00254	CcSEcCtD
Secobarbital—Dizziness—Lisinopril—systemic scleroderma	0.000827	0.00252	CcSEcCtD
Secobarbital—Nausea—Mycophenolic acid—systemic scleroderma	0.000825	0.00252	CcSEcCtD
Secobarbital—Syncope—Prednisone—systemic scleroderma	0.000817	0.00249	CcSEcCtD
Secobarbital—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000808	0.00246	CcSEcCtD
Secobarbital—Loss of consciousness—Prednisone—systemic scleroderma	0.0008	0.00244	CcSEcCtD
Secobarbital—Vomiting—Lisinopril—systemic scleroderma	0.000796	0.00243	CcSEcCtD
Secobarbital—Rash—Lisinopril—systemic scleroderma	0.000789	0.0024	CcSEcCtD
Secobarbital—Dermatitis—Lisinopril—systemic scleroderma	0.000788	0.0024	CcSEcCtD
Secobarbital—Headache—Lisinopril—systemic scleroderma	0.000784	0.00239	CcSEcCtD
Secobarbital—Anxiety—Prednisone—systemic scleroderma	0.000773	0.00235	CcSEcCtD
Secobarbital—Nausea—Lisinopril—systemic scleroderma	0.000743	0.00227	CcSEcCtD
Secobarbital—Shock—Prednisone—systemic scleroderma	0.000731	0.00223	CcSEcCtD
Secobarbital—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000725	0.00221	CcSEcCtD
Secobarbital—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000697	0.00212	CcSEcCtD
Secobarbital—Rash—Mycophenolate mofetil—systemic scleroderma	0.000691	0.00211	CcSEcCtD
Secobarbital—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000691	0.00211	CcSEcCtD
Secobarbital—Headache—Mycophenolate mofetil—systemic scleroderma	0.000687	0.00209	CcSEcCtD
Secobarbital—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000651	0.00198	CcSEcCtD
Secobarbital—Constipation—Prednisone—systemic scleroderma	0.000635	0.00194	CcSEcCtD
Secobarbital—Confusional state—Methotrexate—systemic scleroderma	0.000626	0.00191	CcSEcCtD
Secobarbital—Feeling abnormal—Prednisone—systemic scleroderma	0.000612	0.00187	CcSEcCtD
Secobarbital—Body temperature increased—Prednisone—systemic scleroderma	0.000587	0.00179	CcSEcCtD
Secobarbital—Hypotension—Methotrexate—systemic scleroderma	0.00058	0.00177	CcSEcCtD
Secobarbital—Somnolence—Methotrexate—systemic scleroderma	0.000552	0.00168	CcSEcCtD
Secobarbital—Hypersensitivity—Prednisone—systemic scleroderma	0.000548	0.00167	CcSEcCtD
Secobarbital—Feeling abnormal—Methotrexate—systemic scleroderma	0.000512	0.00156	CcSEcCtD
Secobarbital—Dizziness—Prednisone—systemic scleroderma	0.000491	0.0015	CcSEcCtD
Secobarbital—Body temperature increased—Methotrexate—systemic scleroderma	0.000491	0.0015	CcSEcCtD
Secobarbital—Vomiting—Prednisone—systemic scleroderma	0.000472	0.00144	CcSEcCtD
Secobarbital—Rash—Prednisone—systemic scleroderma	0.000469	0.00143	CcSEcCtD
Secobarbital—Dermatitis—Prednisone—systemic scleroderma	0.000468	0.00143	CcSEcCtD
Secobarbital—Headache—Prednisone—systemic scleroderma	0.000466	0.00142	CcSEcCtD
Secobarbital—Hypersensitivity—Methotrexate—systemic scleroderma	0.000458	0.00139	CcSEcCtD
Secobarbital—Nausea—Prednisone—systemic scleroderma	0.000441	0.00135	CcSEcCtD
Secobarbital—Dizziness—Methotrexate—systemic scleroderma	0.000411	0.00125	CcSEcCtD
Secobarbital—Vomiting—Methotrexate—systemic scleroderma	0.000395	0.0012	CcSEcCtD
Secobarbital—Rash—Methotrexate—systemic scleroderma	0.000392	0.00119	CcSEcCtD
Secobarbital—Dermatitis—Methotrexate—systemic scleroderma	0.000391	0.00119	CcSEcCtD
Secobarbital—Headache—Methotrexate—systemic scleroderma	0.000389	0.00119	CcSEcCtD
Secobarbital—Nausea—Methotrexate—systemic scleroderma	0.000369	0.00112	CcSEcCtD
